Pure Bioscience Stock Price Patterns

PURE Stock  USD 0.08  0.0004  0.49%   
In Current reporting cycle, momentum metrics show RSI of 60 for Pure Bioscience, indicating sustained upward pressure. For Pure Bioscience, this reading places momentum above the midline and consistent with a constructive price trend.
Momentum
Buy Extended
 
Oversold
 
Overbought
This OTC forecast view for Pure Bioscience integrates historical patterns with forward-looking signals. Scenario outputs are informational and reflect model-based estimates, not certainties.
The screening view for Pure Bioscience compiles headlines from major news and public sources. The screening aggregates financial press, regulatory news, and public discussion channels. This view for Pure Bioscience relates headline activity to price movement. The information is based on observed attention signals and price data. Values reflect relative positioning against peer attention patterns. The dataset reflects available attention and market inputs.
The hype panel for Pure Bioscience summarizes attention and headline activity. Volatility and performance cues accompany the headline activity summary. Public commentary and news volume are organized to frame price behavior context. This summary is based on available sentiment data without forward-looking claims.
Pure Bioscience after-hype prediction price
    
  $ 0.0857  
The module provides attention context in addition to forecasting models and technical indicators. Earnings data and momentum signals add quantitative depth to the sentiment context. The multi-input framework captures relationships that single-signal views may miss. This content is informational and does not imply direction.
  
Use Pure Bioscience Basic Forecasting Models to cross-verify projections for Pure Bioscience. The model-based reference helps frame projection data within a statistical context.
Experienced Pure Bioscience's investors use mean reversion as a complement to momentum analysis: momentum identifies the trend; mean reversion identifies when that trend has extended beyond sustainable levels.
Intrinsic
Valuation
LowRealHigh
0.000.068.36
Details
Naive
Forecast
LowNextHigh
0.00180.098.39
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.080.080.08
Details
The most actionable insights from Pure Bioscience analysis often emerge from peer comparison rather than standalone review. Pure Bioscience's metrics gain meaning when benchmarked against the best and worst performers in its sector.

After-Hype Price Density Analysis

This probability distribution for Pure Bioscience is built from Monte Carlo simulations that incorporate Pure Bioscience's historical volatility, mean reversion tendencies, and jump risk. The resulting distribution captures a broader range of Pure Bioscience outcomes than simple linear.
   Next price density   
       Expected price to next headline  

Estimiated After-Hype Price Volatility

The boundaries derived from Pure Bioscience's historical news analysis represent the range within which Pure Bioscience's price has typically settled after comparable headline events. Pure Bioscience's after-hype downside and upside margins for the prediction period are 0.00 and 8.39, respectively. Outcomes outside these boundaries are less common but not rare for Pure Bioscience.
Current Value
0.08
0.09
After-hype Price
8.39
Upside
Macroaxis estimates the after-hype price of Pure Bioscience across a 3 months horizon to evaluate where the instrument could settle once headline distortion subsides. Used correctly, the estimate adds context around potential normalization rather than promising a specific realized outcome.

Price Outlook Analysis

Have you ever been surprised when a price of a OTC Stock such as Pure Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pure Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pure Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  1.15 
8.30
  0.06 
  0.02 
1 Events
3 Events
Very soon
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.08
0.09
4.94 
16,633  
Notes

Hype Timeline

Pure Bioscience is at this time traded for 0.08. The company has historical hype elasticity of -0.06, and average elasticity to hype of competition of -0.02. Pure is projected to increase in value after the next headline, with the price projected to jump to 0.0857 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 4.94%, whereas the daily expected return is at this time at 1.15%. The volatility of related hype on Pure Bioscience is about 39373.81%, with the expected price after the next announcement by competition of 0.06. Pure Bioscience currently holds about 511 K in cash with -2.42 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. Given the investment horizon of 90 days the next projected press release will be very soon.
Use Pure Bioscience Basic Forecasting Models to cross-verify projections for Pure Bioscience. The model-based reference helps frame projection data within a statistical context.

Related Hype Analysis

Understanding Pure Bioscience's position within its competitive set supports assessment of whether news affecting a peer is a headwind or tailwind for Pure Bioscience. This distinction requires knowledge of the competitive dynamics specific to Pure Bioscience's industry.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
EXDWExceed World 0.00 12 per month 0.00  0.00  0.00  0.00  0.00 
TNYBFThe Tinley Beverage 0.00 6 per month 0.00  0.00  0.00  0.00  0.00 
HERBYasheng Group-0.03 1 per month 16.96 0.07 76.54 -38.75 123.69
DQWSDSwiss Inc-0.03 13 per month 0.00 -0.04  0.00  0.00  20.51
INDFYIndofood Agri Resources 0.00 14 per month 0.00  0.00  0.00  0.00  0.00 
NPRFFNepra Foods-0.06 7 per month 0.00 -0.01 9.01 -14.46 42.77
CAWWCCA Industries 0.00 0 per month 0.00 -0.04 2.00 -6.67 27.41
NUVIEmo Capital Corp-0.01 7 per month 0.00  0.18 33.00  0.00  199.43
LNLHFLeanLife Health 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
HIGRHi Great Group Holding-0.08 18 per month 0.00  0.02 0.83 -32.83 209.39

Pure Bioscience Additional Predictive Modules

Forecasting Pure Bioscience's price movement relies on structured analysis of indicator behavior, momentum signatures, and historical volatility patterns. Non-stationary data - where mean and variance shift over time - is the norm for Pure, making adaptive models preferable.

Sentiment Indicators & Methodology

Sentiment analysis for Pure Bioscience evaluates news tone, positioning, and narrative momentum. News flow can reinforce structural moves in the underlying exposure set. Pure Bioscience has a market cap of 13.36 M, P/E of 12.49, ROE of -128.79%.

Macroaxis compiles Pure Bioscience metrics from periodic company reporting and market reference feeds and applies consistent transformation rules before display. Not all fields update in real time.

This content is curated and reviewed by:

Gabriel Shpitalnik - Member of Macroaxis Editorial Board
Last reviewed on March 5th, 2026

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Popular Tools for Pure OTC Stock analysis

CEOs Directory
Screen CEOs from public companies around the world
Commodity Directory
Find actively traded commodities issued by global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets